McKesson Posts FY25 Results, Offers FY26 Guidance, to Separate Medical-Surgical Unit

McKesson Reports Strong Q4 and FY2025 Financial Results, Issues Robust FY2026 Guidance, and Announces Intent to Spin Off Medical-Surgical Solutions Segment McKesson Corporation (NYSE: MCK) has reported impressive financial results for the fourth quarter and full fiscal year ended March…

Read MoreMcKesson Posts FY25 Results, Offers FY26 Guidance, to Separate Medical-Surgical Unit

Strong Start for RHÖN-KLINIKUM AG in 2025 as Company Confirms Financial Forecast

RHÖN-KLINIKUM AG Reports Solid Start to Financial Year 2025 Amid Regulatory and Economic Challenges RHÖN-KLINIKUM AG, one of Germany’s largest private healthcare providers, has begun the 2025 financial year on stable footing, reporting solid performance figures despite ongoing sector challenges…

Read MoreStrong Start for RHÖN-KLINIKUM AG in 2025 as Company Confirms Financial Forecast

Sangamo Therapeutics to Host First Quarter 2025 Earnings Conference Call

Sangamo Therapeutics to Release First Quarter 2025 Financial Results and Host Earnings Conference Call on May 12 Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a clinical-stage genomic medicine company developing transformative therapies using its proprietary platform technologies, announced today that it will…

Read MoreSangamo Therapeutics to Host First Quarter 2025 Earnings Conference Call

Chemed Corporation to Participate in the 2025 Bank of America Securities Health Care Conference

Chemed Corporation to Present at the 2025 Bank of America Securities Health Care Conference Chemed Corporation (NYSE: CHE), a leading publicly traded company with two nationally recognized subsidiaries, today announced its participation in the upcoming Bank of America Securities 2025…

Read MoreChemed Corporation to Participate in the 2025 Bank of America Securities Health Care Conference